Suchen
Teva Pharmaceutical Industries Ltd
TEVAZur Watchlist hinzufügen
33.210USD
+1.010+3.14%
Handelsschluss 06/23, 16:00（ET）Kurse um 15 Minuten verzögert
38.24BMarktkapitalisierung
26.97KGV TTM
mehr Informationen über Teva Pharmaceutical Industries Ltd Unternehmen
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd Informationen
BörsenkürzelTEVA
Name des UnternehmensTeva Pharmaceutical Industries Ltd
IPO-datumFeb 06, 2087
CEOFrancis (Richard D)
Anzahl der mitarbeiter33892
WertpapierartDepository Receipt
GeschäftsjahresendeFeb 06
Addresse124 Dvora Hanevi'a St.
StadtTEL AVIV-YAFO
BörseNASDAQ OMX NASDAQ Basic NYSE
LandIsrael
Postleitzahl6944020
Telefon97239148213
Websitehttps://www.tevapharm.com/
BörsenkürzelTEVA
IPO-datumFeb 06, 2087
CEOFrancis (Richard D)
Führungskräfte von Teva Pharmaceutical Industries Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Roberto A. Mignone
Mr. Roberto A. Mignone
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Teva Pharmaceutical Industries Ltd?
Die fünf größten Anteilseigner von Teva Pharmaceutical Industries Ltd sind: Prof. Varda Shalev
Wie viele Institutionen halten Anteile an Teva Pharmaceutical Industries Ltd (TEVA)?
Mit Stand vom 2026Q1 halten 1226 Institutionen Anteile an Teva Pharmaceutical Industries Ltd, mit einem Gesamtmarktwert von etwa 725.07M, was 62.27% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 9191465.00 gestiegen.
Was ist die größte Einnahmequelle von Teva Pharmaceutical Industries Ltd?
Am 2026Q1 erzielte das Geschäft mit Generic products für Teva Pharmaceutical Industries Ltd den höchsten Umsatz in Höhe von 9.42B, was 54.59% des Gesamtumsatzes entspricht.
